News Releases Archives

SARS-CoV-2 Pseudovirus (Update)

by Jake Q | Jun 17, 2020

Thank you for your interest in Montana Molecular’s assays for SARS-CoV-2 research and drug discovery. In a rapidly evolving field, as new insights into the mechanisms of viral entry come to light, we sincerely appreciate your patience and feedback as we continue to...

Live Cell Assays for COVID-19 Drug Screening

by Jake Q | Apr 7, 2020

COVID-19 continues to disrupt life as we know it, but here in Montana we are devising a new brand of biosensors for our heroes who are testing antivirals to fight SARS-CoV-2. Here’s what’s in our pipeline for targeting viral entry into host cells. Targeting Viral...

BPS 2020 Annual Meeting

by MT Molecular | Feb 17, 2020

We’re hosting a booth (#121) and poster at BPS 2020 Annual Meeting in San Diego this week: Poster Presentation 2232-Pos, Board B502 Neurodegenerative Disease and cAMP Signaling Dynamics Tues. Feb. 18, 2:45-3:45 PM Company About Us News Contact Us Careers...

SLAS 2020 International Conference & Exhibition

by MT Molecular | Jan 27, 2020

We’re hosting a booth and poster at SLAS 2020 International Conference & Exhibition in San Diego this week: Poster Presentation 1018-D Live Cell Assays Reveal New Patterns of Cell Signaling in Neurodegenerative Mutants Tues. Jan 28 5:00-6:00 PM Company About...

Society for Neuroscience 2019 – Poster Presentation

by Jake Q | Oct 22, 2019

We know it’s early in the morning, and late in the #SfN2019 week, but don’t miss your chance to meet up with Scott Martinka, Senior Scientist and assay developer at Montana Molecular. Ask Scott to tell you all about this new kinetic method for measuring GPCR agonist...

NIH HEAL Initiative Awards Montana Molecular for Biological Assays in Pain and Addiction

by Jake Q | Oct 8, 2019

BOZEMAN, Mont.–(BUSINESS WIRE)–Montana Molecular announced today that the company has received two new awards from the National Institutes of Health (NIH). These highly competitive awards will support optimization and validation of preclinical cell-based...